Your leading voice in digital health news
Twitter X Logo

Leap forward for vaccines, pandemic preparedness

2 December 2025
By Pulse+IT
The CSL Seqirus’ state-of-the-art cell-based influenza vaccine and antivenom manufacturing facility was officially opened today in Melbourne. The Australian-owned and operated facility uses innovative technology to manufacture seasonal and pandemic flu vaccines for Australia and the world.  It is the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere and makes Australia one of only three […]

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Copyright © 2025 Pulse IT Communications Pty Ltd. No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher. If your organisation is featured in a Pulse+IT article you can purchase the permission to reproduce the article here.
Website Design by Get Leads AU.

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down